Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
BioCryst sells Orladeyo business in Europe; UCB gets a Phase 3 win for Fintepla
Last week
News Briefing
Innovent brings a new mechanism to obesity market with China approval
Last week
China
Pharma
FDA head Makary’s short-lived CRL ask on KalVista’s drug raises more concerns of political intervention
Last week
FDA+
Alphabet’s Calico inks $25M licensing deal for Mabwell’s IL-11 programs
Last week
Deals
R&D
Bill Meury brings new perspective to Incyte as Hoppenot retires; Ex-MorphoSys CEO leads revitalized Vor Bio
Last week
Peer Review
A dinner in Paris revived talks for Sanofi's $9.5B deal for Blueprint
Last week
Deals
Pharma
Gilead stops RSV antiviral trials after low incidence rates during recent season
Last week
R&D
Pharma
AI scribes are evolving
Last week
Health Tech
Judge says CVS Caremark owes $95M in false claims case
Last week
Pharma
Law
Debate on a long-scrutinized vaccine ingredient consumes CDC panel in its second day
Last week
R&D
FDA+
Altimmune posts mixed results for incretin drug in MASH; stock is halved
Last week
R&D
Edgewise details pivotal plans in Becker muscular dystrophy; Kymera’s $250M offering
Last week
News Briefing
Opus, Viatris say presbyopia drug succeeds in Phase 3
Last week
R&D
Why Commure, one of healthcare's most deal-hungry startups, plans to buy more scribes
Last week
Startups
Health Tech
Exclusive: Handspring Health raises $12M to provide more complex youth mental healthcare
Last week
Financing
Health Tech
Bharat, GSK to cut malaria vaccine price; Emergent's US stockpile deal expands
Last week
Manufacturing
Vor Bio bounces back with autoimmune drug pact, $175M private placement
Last week
Financing
Deals
Novartis strikes cardiovascular discovery deal with Flagship’s ProFound
Last week
Deals
R&D
Watch Post-Hoc Live: A conversation about ACIP and the future of vaccines
Last week
Editor's note
R&D
Medicare drug spending will slow due to IRA price negotiations, CMS economists predict
2 weeks ago
Pharma
Ex-CBER chief Marks criticizes how FDA crafted its new Covid vaccine framework
2 weeks ago
R&D
Pharma
Rebuilt CDC panel will reassess cumulative vaccine effects, older shots
2 weeks ago
R&D
FDA+
Trump’s CDC nominee sidesteps Senate grilling on controversial changes
2 weeks ago
People
Pharma
Kymera inks deal with Gilead as partnership with Sanofi faces a switch-up
2 weeks ago
R&D
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page
